Published October 5, 2018
| Version v1
Preprint
Open
Purification of more ACVR1, some crystal hits, and a few fine screens
Description
Purification protocol for ACVR1, crystal screens with M4K compounds and fine screens of hits.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].
Files
Files
(12.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:eaa9fd5dc03b84049aea3b2519f44e89
|
12.3 MB | Download |